Wall Street brokerages predict that NCS Multistage Holdings Inc (NASDAQ:NCSM) will post $48.62 million in sales for the current quarter, according to Zacks Investment Research. Four analysts have provided estimates for NCS Multistage’s earnings. The highest sales estimate is $52.59 million and the lowest is $45.88 million. NCS Multistage reported sales of $36.86 million in the same quarter last year, which indicates a positive year-over-year growth rate of 31.9%. The firm is expected to issue its next earnings results on Tuesday, August 14th.
On average, analysts expect that NCS Multistage will report full year sales of $280.29 million for the current financial year, with estimates ranging from $275.28 million to $285.57 million. For the next financial year, analysts expect that the company will post sales of $372.35 million per share, with estimates ranging from $348.98 million to $419.03 million. Zacks Investment Research’s sales calculations are a mean average based on a survey of sell-side analysts that cover NCS Multistage.
NCS Multistage (NASDAQ:NCSM) last posted its earnings results on Tuesday, May 8th. The company reported $0.21 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.16 by $0.05. NCS Multistage had a net margin of 3.06% and a return on equity of 2.90%. The firm had revenue of $70.69 million for the quarter, compared to the consensus estimate of $69.65 million.
A number of analysts recently issued reports on the company. BidaskClub downgraded NCS Multistage from a “sell” rating to a “strong sell” rating in a research report on Thursday, June 7th. Zacks Investment Research upgraded NCS Multistage from a “sell” rating to a “hold” rating in a report on Friday, March 16th. ValuEngine downgraded NCS Multistage from a “sell” rating to a “strong sell” rating in a report on Tuesday, May 22nd. Finally, JPMorgan Chase & Co. reiterated a “neutral” rating and issued a $20.00 price objective (up previously from $19.00) on shares of NCS Multistage in a report on Tuesday, March 13th. Two analysts have rated the stock with a sell rating, two have given a hold rating, six have given a buy rating and one has assigned a strong buy rating to the stock. NCS Multistage presently has a consensus rating of “Buy” and a consensus price target of $23.88.
NCSM traded up $0.54 during trading on Thursday, reaching $13.60. 580,608 shares of the company traded hands, compared to its average volume of 169,558. The company has a debt-to-equity ratio of 0.06, a current ratio of 3.69 and a quick ratio of 2.74. NCS Multistage has a 12-month low of $12.57 and a 12-month high of $25.96. The firm has a market cap of $586.50 million, a P/E ratio of 68.00 and a beta of 0.44.
In related news, President Marty Stromquist sold 131,637 shares of the firm’s stock in a transaction that occurred on Friday, May 11th. The stock was sold at an average price of $17.05, for a total transaction of $2,244,410.85. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, EVP Kevin Trautner sold 5,400 shares of the firm’s stock in a transaction that occurred on Thursday, May 17th. The stock was sold at an average price of $17.33, for a total value of $93,582.00. The disclosure for this sale can be found here. Company insiders own 11.70% of the company’s stock.
A number of large investors have recently added to or reduced their stakes in NCSM. Northern Trust Corp increased its holdings in shares of NCS Multistage by 2.9% in the first quarter. Northern Trust Corp now owns 126,216 shares of the company’s stock valued at $1,894,000 after purchasing an additional 3,568 shares in the last quarter. TIAA CREF Investment Management LLC boosted its stake in NCS Multistage by 8.0% in the 4th quarter. TIAA CREF Investment Management LLC now owns 49,674 shares of the company’s stock worth $732,000 after purchasing an additional 3,692 shares in the last quarter. JPMorgan Chase & Co. boosted its stake in NCS Multistage by 54.5% in the 1st quarter. JPMorgan Chase & Co. now owns 12,257 shares of the company’s stock worth $184,000 after purchasing an additional 4,322 shares in the last quarter. Bank of New York Mellon Corp boosted its stake in NCS Multistage by 25.7% in the 4th quarter. Bank of New York Mellon Corp now owns 40,812 shares of the company’s stock worth $602,000 after purchasing an additional 8,357 shares in the last quarter. Finally, Bamco Inc. NY boosted its stake in NCS Multistage by 24.3% in the 4th quarter. Bamco Inc. NY now owns 68,100 shares of the company’s stock worth $1,004,000 after purchasing an additional 13,300 shares in the last quarter. Hedge funds and other institutional investors own 94.11% of the company’s stock.
NCS Multistage Company Profile
NCS Multistage Holdings, Inc provides engineered products and support services for oil and natural gas well completions and field development strategies in the United States and internationally. The company's products include casing-installed sliding sleeves, downhole frac isolation assemblies, sand jet perforating products, spotfrac systems, ballshift sliding sleeves, airlock casing buoyancy systems, liner hanger systems, and spectrum tracer services.
Get a free copy of the Zacks research report on NCS Multistage (NCSM)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for NCS Multistage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NCS Multistage and related companies with MarketBeat.com's FREE daily email newsletter.